REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/05/2026
Back to search
Official data from USPTO
MNEMO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MNEMO THERAPEUTICS
ST13
US500000079289569Class
5, 44
Filing
79289569
Registration
6236055
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/06/2026
Trademark type
Word
Nice classes
5, 44
Filing date
05/07/2020
Registration date
01/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/05/2021
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
LATTUCA,FRANK J
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. T. (pessoa física)
Representatives
Glenn A. Gundersen Dechert LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of cancerous tumors and auto-immune or infectious diseases; chemical preparations for pharmaceutical use for the treatment of cancerous tumors and auto-immune or infectious diseases; chemical preparations for medical use for the treatment of cancerous tumors and auto-immune or infectious diseases; diagnostic preparations for medical use for the treatment of cancerous tumors and auto-immune or infectious diseases
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/02/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/30/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/14/2021
FIMP
FINAL DISPOSITION PROCESSED
04/13/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/05/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/20/2020
PUBO
PUBLISHED FOR OPPOSITION
10/20/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/19/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/30/2020
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/07/2020
RFRR
REFUSAL PROCESSED BY MPU
09/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2020
CNRT
NON-FINAL ACTION WRITTEN
08/07/2020
DOCK
ASSIGNED TO EXAMINER
08/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens MNEMO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.